Company: ST
Filing Date: 2025-05-08
Form Type: 10-Q
Source: 0001477294-25-000067
Chunk: 8

Company: Sensata Technologies Holding plc
Filing Date: 2025-05-08
Form: 10-Q
Item: Item 1
Chunk 8
---
2025, and 2024:For the three months endedMarch 31, 2025March 31, 20242H 2024 Plan, net $2,454 $— Q3 2023 Plan, net918 598 Other restructuring and other charges, netSeverance charges, net (80)(9)Facility and other exit costs— 168 Loss on sale of business 4,420 — Acquisition-related compensation arrangements (1)— 955 Other(732)(930)Restructuring and other charges, net$6,980 $782 ___________________________________(1)    Acquisition-related compensation arrangements consist of incentive compensation to previous owners of companies we have acquired. Payment is generally tied to technical and/or financial targets set at the time of acquisition.The following table presents a rollforward of our severance liability, which is primarily related to the 2H 2024 Plan, for the three months ended March 31, 2025: TotalBalance as of December 31, 20246,087 Charges, net of reversals553 Payments(2,142)Foreign currency remeasurement71 Balance as of March 31, 2025$4,569 The severance liability as of March 31, 2025 and December 31, 2024 was entirely recorded in accrued expenses and other current liabilities on our condensed consolidated balance sheets.

6. Other, Net 

The following table presents the components of other, net for the three months ended March 31, 2025 and 2024: For the three months ended March 31, 2025March 31, 2024Currency remeasurement (loss)/gain on net monetary assets$(459)$1,031 (Loss)/gain on foreign currency forward contracts(1,576)680 Gain on commodity forward contracts4,419 1,099 Gain/(loss) on equity investments, net (1)15 (13,287)Net periodic benefit cost, excluding service cost(527)(841)Other256 (226)Other, net$2,128 $(11,544)

10

___________________________________(1)    The three months ended March 31, 2024 primarily includes a loss on an equity investment that does not have a readily determinable fair value for which we use the measurement alternative prescribed in FASB ASC Topic 321, Investments—Equity Securities. Refer